Evaluation of plasma ACTH, α-melanocyte-stimulating hormone, and insulin concentrations during various photoperiods in clinically normal horses and ponies and those with pituitary pars intermedia dysfunction

Journal of the American Veterinary Medical Association

Volumn 235, Issue 6, 2009, Pages 715-722

  Beech, Jill ^a   Boston, Raymond C ^a   McFarlane, Dianne ^b   Lindborg, Sue ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b OKLAHOMA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERMEDIN; CORTICOTROPIN; INSULIN;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; FEMALE; HORSE; HORSE DISEASE; HYPOPHYSIS DISEASE; HYPOPHYSIS INTERMEDIATE LOBE; MALE; METABOLISM; PHOTOPERIODICITY;

ADRENOCORTICOTROPIC HORMONE; ALPHA-MSH; ANIMALS; FEMALE; HORSE DISEASES; HORSES; INSULIN; MALE; PHOTOPERIOD; PITUITARY DISEASES; PITUITARY GLAND, INTERMEDIATE;

ANIMALIA; EQUIDAE;

EID: 70349630078     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.235.6.715     Document Type: Article

References (40)

1. Donaldson MT, McDonnell SM, Schanbacher BJ, et al. Variation in plasma adrenocorticotropic hormone concentration and dexamethasone suppression test results with season, age, and sex in healthy ponies and horses. J Vet Intern Med 2005;19:217-222.
2. McFarlane D, Donaldson MT, McDonnell SM, et al. Effects of season and sample handling on measurement of plasma α-melanocyte-stimulating hormone concentrations in horses and ponies. Am J Vet Res 2004;65:1463-1468.
3. Beech J, Boston R, Lindborg S, et al. Adrenocorticotropin concentration following administration of thyrotropin-releasing hormone in healthy horses and those with pituitary pars intermedia dysfunction and pituitary gland hyperplasia. J Am Vet Med Assoc 2007;231:417-425.
4. Dybdal NO, Hargreaves KM, Madigan JE, et al. Diagnostic testing for pituitary pars intermedia dysfunction in horses. J Am Vet Med Assoc 1994;204:627-632.
5. Orth DN, Holscher MA, Wilson MG, et al. Equine Cushing's disease: plasma immunoreactive proopiolipomelanocortin peptide and Cortisol levels basally and in response to diagnostic tests. Endocrinology 1982;110:1430-1441.
6. McFarlane D, Beech J, Cribb A. Alpha melanocyte stimulating hormone release in response to thyrotropin releasing hormone in healthy horses, horses with pituitary pars intermedia dysfunction and equine pars intermedia explants. Domest Anim Endocrinol 200630:276-288.
7. Okada T, Shimomuro T, Oikawa M, et aL Immunocytochemical localization of adrenocorticotropic hormone-immunoreactive cells of the pars intermedia in Thoroughbreds. Am J Vet Res 1997;58:920-924.
8. Yoshikawa H, Oishi H, Sumi A, et al Spontaneous pituitary adenomas of the pars intermedia in 5 aged horses: histopathological, immunohistochemical and ultrastructural studies. J Equine Sci 2001;12:119-126.
9. Orth DN, Nicholson WE. Bioactive and immunoreactive adrenocorticotropin in normal equine pituitary and in pituitary tumors of horse with Cushing's disease. Endocrinology 1982;111:559-563.
10. Boujon CE, Bestetti GE, Meier HP, et al. Equine pituitary adenoma: a functional and morphological study. J Comp Pathol 1993;109:163-178.
11. Van der Kolk JH, Wensing T, Kalsbeek HC, et al. Laboratory diagnosis of equine pars intermedia adenoma. Dornest Anim Endocrinol 1995;12:35-39.
12. McGowan CM, Frost R, Pfeiffer DV et al. Serum insulin concentrations in horses, with equine Cushings syndrome: response to a Cortisol inhibitor and prognostic value. Equine Vet J 2004;36:295-298.
13. Evans JW, Thompson PG, Winget CM. Glucose and insulin biorhythms in the horse. J S Afr Vet Assoc 1974;45:317-329.
14. Jeffcott LB, Field JR. Glucose tolerance and insulin sensitivity in ponies and Standardbred horses. Equine Vet J 1986;18:97-101.
15. Firshman AM, Valberg SJ. Factors affecting clinical assessment of insulin sensitivity in horses. Equine Vet J 2007;39:567-575.
16. Freestone JF, Beadle R, Shoemaker K, et al. Improved insulin sensitivity in hyperinsulinemic ponies through physical conditioning and controlled feed intake. Equine Vet J 1992;24:187-190.
17. Hoffman RM, Boston RC, Stefanovski D, et al. Obesity and diet affect glucose dynamics and insulin sensitivity in Thoroughbred geldings. J Anim Sci 2003;81:2333-2342.
18. Bailey SR, Habershon-Butcher JL, Ransom KJ, et al. Hypertension and insulin resistance in a mixed-breed population of ponies predisposed to laminitis. Am J Vet Res 2008;69:122-129.
19. Weather Underground Web site. Available at: www.wunderground.com. Accessed Mar 2007.
20. Henneke DR, Potter GD, Krieder JL, et al. Relationship between condition score, physical measurements and body fat percentage in mares. Equine Vet J 1983;15:371-372.
21. Kooistra HS, Greven SH, Mol JH, et al Pulsatile secretion of a-MSH and die differential effects of dexamethasone and Haloperidol on the secretion of α-MSH and ACTH in dogs. J Endocrinol 1997;152:113-121.
22. Peterson ME, Kemppainen RJ, Orth DN. Plasma concentrations of immunoreactive proopiomelanocortin peptides and Cortisol in clinically normal cats. Am J Vet Res 1994;55:295-300.
23. Kemppainen RJ, Peterson ME. Domestic cats show episodic variation in plasma concentrations of adrenocorticotropin, alpha-melanocyte stimulating hormone (α-MSH), Cortisol, and thyroxin with circadian variation in plasma a-MSH concentrations. EurJ Endocrinol 1996;134:602-609.
24. Livesey JH, Donald RA, Irvine CH, et al. The effects of Cortisol, vasopressin (AVP), and corticotropin releasing factor administration on pulsatile adrenocorticotropin, alpha-melanocyte stimulating hormone, and AVP secretion in the pituitary venous effluent of the horse. Endocrinology 1988;123:713-720.
25. Engler D, Pham T, Fullerton MJ. Evidence for an ultradian secretion of adrenocorticotropin beta endorphin, and alpha-melanocyte stimulating hormone by the ovine anterior and intermediate pituitary. Neuroendocrinology 1989;49:349-360.
26. Pichler R, Crespillo C, Maschek W, et al. Plasma levels of alpha melanotropin and ACTH like immunoreactivities do not vary by season or skin type in women from southern and central Europe. Neuropeptides 2004;38:325-330.
27. Altmeyer R, Stohr L, Holzmann H. Seasonal rhythm of the plasma level of alpha-melanocyte stimulating hormone. J invest Dermatol 1986;86:454-456.
28. Altmeyer P, Holzmann H, Stõhr L, et al. The relationship between α-MSH level and coat colour in white Camarque horses. J Invest Dermatol 1984;82:199-201.
29. Guerin MV, Deed JR, Kennaway DJ, et al. Plasma melatonin in the horse: measurements in natural photoperiod and in acutely extended darkness throughout the year. J Pineal Res 1995;19:7-15.
30. Haritou SJA, Zylstra R, Ralli C, et al. Seasonal changes in circadian peripheral plasma concentrations of melatonin, serotonin, dopamine, and Cortisol in aged horses with Cushings disease under natural photoperiod. J Neuroendocrinal 2008;20:988-996.
31. Millington WR, Dybdal N, Dawson R, et al. Equine Cushings disease's differential regulation of B endorphin processing in tumours of the intermediate pituitary. Endocrinology 1988;123:1598-1604.
32. McFarlane D, Dybdal N, Donaldson MT, et al. Nitration and increased alpha-synuclein expression associated with dopaminergic neurodegeneration in equine pituitary pars intermedia dysfunction (PPID). J Neuroendocrinol 2005;17:73-80.
33. Lincoln GA, Clark IJ. Photoperiodically-induced cycles in the secretion of prolactin in hypothalamo-pituitary disconnected rams: evidence for translation of the melatonin signal in the pituitary gland. J Neuroendocrinol 1994;6:251-260.
34. Lincoln GA, Rhind SM, Pompolo S, et al. Hypothalamic control of photoperiod induced cycles in food intake, body weight and metabolic hormones in rams. Am J Physiol Regul Integr Comp Physiol 2001;281:R76-R90.
35. Alila-Johansson A, Eriksson L, Soveri T, et al. Seasonal variations in endogenous serum melatonin profiles in goats-a difference between spring and fall. J Biol Rhythms 2001;16:254-263.
36. Alila-Johansson A, Eriksson L, Soveri T, et al. Serum Cortisol levels in goats exhibit seasonal but not daily rhythmicity. Chronobiol Int 2003;20:65-79.
37. Lincoln GA, Baker BI. Seasonal and photoperiod induced changes in the secretion of alpha melanocyte stimulating hormone in Soay sheep: temporal relationships with changes in beta-endorphin prolactin follicle stimulating hormone, activity of the gonads and growth of pelage and horns. J Endocrinol 1995;144:471-481.
38. Frank N, Elliott SB, Boston RC. Effects of long-term oral administration of levothyroxine sodium on glucose dynamics in healthy adult horses. Am J Vet Res 2008;69:76-81.
39. Donaldson MT, LaMonte BH, Morresey P, et al. Treatment with pergolide or cyproheptadine of pituitary pars intermedia dysfunction (equine Cushings disease). J Vet Intern Med 2002;16:742-746.
40. Schott HC II, Coursen CL, Eberhart SW, et al. The Michigan Cushing's project, in Proceedings. 47th Annu Conv Am Assoc Equine Pract 2001;47:22-24.